NASDAQ:FWP

Forward Pharma A/S - FWP Stock Forecast, Price & News

$3.73

-0.24 (-6.05%)

(As of 08/16/2022 12:00 AM ET)

Add

Compare

Today's Range: $3.65
▼
$3.87
50-Day Range: $3.62
▼
$5.35
52-Week Range: $3.61
▼
$9.74

Volume: 4,290 shs
Average Volume: 8,040 shs
Market Capitalization: $26.45 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

About Forward Pharma A/S (NASDAQ:FWP) Stock

Forward Pharma A/S does not have significant operations. Previously, it operated as a biopharmaceutical company that focused on developing FP187 proprietary formulation of dimethyl fumarate for the treatment of inflammatory and neurological indications. Forward Pharma A/S was incorporated in 2005 and is headquartered in Copenhagen, Denmark.

Forward Pharma A/S Stock Down 3.0 %

Shares of Forward Pharma A/S stock traded down $0.12 on Tuesday, reaching $3.85. 200 shares of the company were exchanged, compared to its average volume of 6,789. The stock has a fifty day moving average price of $4.26 and a 200-day moving average price of $5.10. Forward Pharma A/S has a fifty-two week low of $3.61 and a fifty-two week high of $9.74.

Analysts Set New Price Targets

Separately, StockNews.com started coverage on Forward Pharma A/S in a report on Tuesday, August 9th. They issued a "sell" rating for the company.

Receive FWP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Forward Pharma A/S and its competitors with MarketBeat's FREE daily newsletter.

FWP Stock News Headlines

August 10, 2022 | usatoday.com

US forward Matthew Hoppe joins 2nd-tier Middlesbrough

August 10, 2022 | americanbankingnews.com

Forward Pharma A/S (NASDAQ:FWP) Now Covered by Analysts at StockNews.com

August 8, 2022 | finance.yahoo.com

Fortune and Great Place to Work® Name Forward Networks One of the 2022 Best Small Workplaces™, Ranking #20 Nationally

August 2, 2022 | americanbankingnews.com

Forward Pharma A/S (NASDAQ:FWP) Receives New Coverage from Analysts at StockNews.com

July 2, 2022 | thestreet.com

Forward Pharma A/S News

April 11, 2022 | investing.com

Forward Pharma Reports FY 21 EPS of $0.02

April 8, 2022 | finance.yahoo.com

Forward Pharma Reports Financial and Operating Results for the Year Ended December 31, 2021

December 16, 2021 | benzinga.com

Forward Pharma Shares Resume Trading, Pull Back From Highs

December 16, 2021 | benzinga.com

Forward Pharma Has Been Granted Australian Patent Titled 'Combination therapy for treatment of multiple sclerosis'

September 7, 2021 | finance.yahoo.com

Why is Forward Pharma Stock Plunging During Premarket Tuesday?

September 6, 2021 | finance.yahoo.com

Forward Pharma Announces the Decision of the Technical Board of Appeal of the European Patent Office in the EP2801355 Appeal Hearing

June 28, 2021 | finance.yahoo.com

We're Hopeful That Forward Pharma (NASDAQ:FWP) Will Use Its Cash Wisely

June 14, 2021 | finance.yahoo.com

Is Forward Pharma A/S (FWP) Going to Burn These Hedge Funds?

June 11, 2021 | marketwatch.com

Forward Pharma ADRs Up 26%

April 14, 2021 | finance.yahoo.com

Forward Pharma Reports Financial and Operational Results from the Year Ended December 31, 2020

January 10, 2021 | benzinga.com

Ascendis Pharma A/S Provides Vision 3x3 Update at 39th Annual J.P. Morgan Healthcare Conference

November 19, 2020 | barrons.com

Forward Pharma A/S ADR

November 13, 2020 | seekingalpha.com

Zealand Pharma A/S (ZLDPF) CEO Emmanuel Dulac on Q3 2020 Results - Earnings Call Transcript

October 20, 2020 | nasdaq.com

Forward Pharma A/S American Depositary Shares (FWP)

October 3, 2020 | in.finance.yahoo.com

Forward Pharma A/S (FWP)

September 28, 2020 | benzinga.com

Ascendis Pharma A/S Announces Preliminary Six-...

September 15, 2020 | finance.yahoo.com

Ascendis Pharma A/S Announces Support for Children’s Growth Awareness Week and Day 2020

August 28, 2020 | seekingalpha.com

Ascendis Pharma A/S (ASND) CEO Jan Mikkelsen on Q2 2020 Results - Earnings Call Transcript

August 6, 2020 | markets.businessinsider.com

Zealand Pharma hosts conference call on August 13 at 4 pm CET (10am ET) to present second quarter results for 2020

August 4, 2020 | businesswire.com

LEO Pharma Announces U.S. Food and Drug Administration Fast Track Designation for delgocitinib Cream for the Treatment of Adults With Moderate-to-severe Chronic Hand Eczema

See More Headlines

30 days | 90 days | 365 days | Advanced Chart

Receive FWP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Forward Pharma A/S and its competitors with MarketBeat's FREE daily newsletter.

FWP Company Calendar

Last Earnings: 9/01/2016
Today: 8/16/2022
Fiscal Year End: 12/31/2022

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceutical preparations
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:FWP
CUSIP: N/A
CIK: 1604924
Web: www.forward-pharma.com
Phone: (453) 344-4242
Fax: N/A
Employees: 4
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 117.44
Quick Ratio: 117.44

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $10.09 per share
Price / Book: 0.37

Miscellaneous

Outstanding Shares: 7,091,000
Free Float: N/A
Market Cap: $26.45 million
Optionable: Not Optionable
Beta: 1.37

Key Executives

Mr. Florian Schonharting M.Sc. (Econ) (Age 53)
Co-Founder & Chairman
Dr. Claus Bo Søndergaard Svendsen M.D. (Age 45)
Ph.D., Chief Exec. Officer
Mr. Thomas Carbone (Age 65)
VP of Fin. & Controller

Key Competitors

View All Competitors

Insiders & Institutions

Renaissance Technologies LLC
Sold 10,000 shares on 8/13/2022
Ownership: 0.204%

View All Insider Transactions
View All Institutional Transactions

FWP Stock - Frequently Asked Questions

How have FWP shares performed in 2022?: Forward Pharma A/S's stock was trading at $5.97 at the beginning of 2022. Since then, FWP shares have decreased by 37.5% and is now trading at $3.73.
View the best growth stocks for 2022 here.
How were Forward Pharma A/S's earnings last quarter?: Forward Pharma A/S (NASDAQ:FWP) announced its quarterly earnings data on Thursday, September, 1st. The biotechnology company reported ($0.32) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.26) by $0.06.
What other stocks do shareholders of Forward Pharma A/S own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Forward Pharma A/S investors own include Gilead Sciences (GILD), SCYNEXIS (SCYX), AbbVie (ABBV), Inovio Pharmaceuticals (INO), Sorrento Therapeutics (SRNE), Celldex Therapeutics (CLDX), Catalyst Pharmaceuticals (CPRX), Micron Technology (MU), Nabriva Therapeutics (NBRV) and Onconova Therapeutics (ONTX).
What is Forward Pharma A/S's stock symbol?: Forward Pharma A/S trades on the NASDAQ under the ticker symbol "FWP."

Who are Forward Pharma A/S's major shareholders?: Forward Pharma A/S's stock is owned by many different institutional and retail investors. Top institutional investors include Renaissance Technologies LLC (0.20%).
How do I buy shares of Forward Pharma A/S?: Shares of FWP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Forward Pharma A/S's stock price today?: One share of FWP stock can currently be purchased for approximately $3.73.
How much money does Forward Pharma A/S make?: Forward Pharma A/S (NASDAQ:FWP) has a market capitalization of $26.45 million.
How can I contact Forward Pharma A/S?: Forward Pharma A/S's mailing address is OSTERGADE 24A 1, COPENHAGEN G7, 1100. The official website for the company is www.forward-pharma.com. The biotechnology company can be reached via phone at (453) 344-4242 or via email at investors@forward-pharma.com.

This page (NASDAQ:FWP) was last updated on 8/17/2022 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms